Genestra Brands Multi + Pro M50 +
Natural health product licensed in Canada
- Licence holder
- Seroyal International
- NPN or DIN-HM
- 80039063
- Status
- Inactive licence
- Licence date
- 29 January 2013
- Revision date
- 9 April 2015
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Chrome: up to 120 µg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Manganèse: up to 4.5 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 3.5 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 24.9 µg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 6.9 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 300 µg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Fer: up to 15.9 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 14 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Sélénium: up to 300 µg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (255 µg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Chrome Source : Polynicotinate de chrome (III) | 40 mcg | 120 µg |
| Serenoa repens Source : Fruit Extraction ratio : 15:1 Dry plant equivalent : 500 mg | 33.3 mg | Not calculated |
| Vitamine A Source : Acétate de vitamine A Potency : 2,000 UI | 600 mcg EAR | Not calculated |
| Inositol Source : Inositol | 16.7 mg | Not calculated |
| Lactobacillus acidophilus Source : Cellule entière | 667 Millions d'UFC | Not calculated |
| Lactobacillus acidophilus Source : CUL-60 | 667 Millions d'UFC | Not calculated |
| Folate Source : Acide folique | 267 mcg | Not calculated |
| Manganèse Source : Citrate de manganèse (II) | 1.5 mg | 4,500 µg |
| Riboflavine Source : Riboflavine | 1.7 mg | 5,100 µg |
| Vitamine D Source : Cholécalciférol Potency : 333 UI | 8.3 mcg | 24.9 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 2.3 mg | 6,900 µg |
| Vitamine B12 Source : Méthylcobalamine | 33.3 mcg | 99.9 µg |
| Sélénium Source : Sélénométhionine | 100 mcg | 300 µg |
| Vanadium Source : Sulfate de vanadyle (IV) | 10 mcg | Not calculated |
| Choline Source : Bitartrate de choline | 16.7 mg | Not calculated |
| Fer Source : Fumarate ferreux | 5.3 mg | 15,900 µg |
| Vitamin K1 Source : Phylloquinone | 20 mcg | 60 µg |
| Acide L-alpha-acétamido-bêta-mercaptopropionique Source : N-Acétyl-L-cystéine | 16.7 mg | Not calculated |
| Silicium Source : Dioxyde de silicium | 6.7 mg | Not calculated |
| Lutéine Source : Tagetes erecta - Fleur | 2.7 mg | Not calculated |
| Niacinamide Source : Niacinamide | 21.3 mg | Not calculated |
Non-medicinal ingredients
Silica, Hypromellose, Palmitate d'ascorbyle
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 1 Capsule | 3 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Used in Herbal Medicine as a tonic to help relieve general debility and/or to aid convalescence. Used in Herbal Medicine to help improve mental and/or physical performance after periods of mental and/or physical exertion. Used in Herbal Medicine to help relieve the urologic symptoms (e.g. weak urine flow, incomplete voiding, frequent daytime and night time urination) associated with mild to moderate benign prostatic hyperplasia. Provides live microorganisms that temporarily modify gut flora. Probiotics that temporarily modify gut flora. Source of probiotics. A factor in the maintenance of good health. Provides antioxidants for the maintenance of good health. Helps in the development and maintenance of night vision, bones, cartilage, teeth and gums. Helps the body to metabolize carbohydrates, fats and proteins and provides support for healthy glucose metabolism. Helps in the absorption and use of calcium and phosphorous. Helps to form red blood cells and helps in their proper function. Helps in tissue formation and in wound healing. Helps to produce and repair connective tissue. Helps normal growth and development. Helps to maintain cardiovascular health, eyesight, skin, membrane and immune function. Helps in the function of the thyroid gland.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80039063
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2015. Photograph the packaging to check whether it has changed. Photograph the packaging